Search references for TEBIDEUTOREXANT. Phrases containing TEBIDEUTOREXANT
See searches and references containing TEBIDEUTOREXANT!TEBIDEUTOREXANT
Chemical compound
Tebideutorexant (developmental code names JNJ-61393215, JNJ-3215) is an orexin antagonist medication which is under development for the treatment of depression
Tebideutorexant
Class of drugs
disorder, insomnia, and sleep apnea, up to phase 3 – half-life 2–3 hours Tebideutorexant (JNJ-61393215, JNJ-3215) – selective OX1 antagonist – under development
Orexin_antagonist
Medication
(C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19
Oveporexton
Pharmaceutical compound
(C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19
Rocavorexant
G-protein-coupled receptor
receptor antagonist TCS-OX2-29 – selective OX2 receptor antagonist Tebideutorexant (JNJ-61393215; JNJ-3215) – selective OX1 receptor antagonist List of
Orexin_receptor
Investigational panic disorder drugs
metabotropic glutamate mGlu2 receptor positive allosteric modulator [5] Tebideutorexant (JNJ-61393215; JNJ-3215) – orexin OX1 receptor antagonist [6] Alprazolam
List of investigational panic disorder drugs
List_of_investigational_panic_disorder_drugs
Insomnia medication
(C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19
Lemborexant
Pharmaceutical compound
(C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19
Ledasorexton
Medication used to treat insomnia
(C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19
Daridorexant
Chemical compound
(C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19
SB-649868
Medication used to treat insomnia
(C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19
Suvorexant
Neuropeptide that regulates arousal, wakefulness, and appetite
(C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19
Orexin
Orexin antagonist compound
(C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19
Almorexant
Experimental anti-insomnia drug
(C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19
Seltorexant
Chemical compound
(C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19
Firazorexton
Chemical compound
(C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19
Danavorexton
Chemical compound
(C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19
Nivasorexant
Pharmaceutical compound
(C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19
Cleminorexton
Novel chemistry compound
(C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19
Alixorexton
Pharmaceutical compound
(C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19
Balumorexton
Stimulating neuropeptide
(C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19
Orexin-A
Investigational anxiety disorder drugs
receptor antagonist [55] SYT-510 – anandamide reuptake inhibitor [56] Tebideutorexant (JNJ-3215; JNJ-61393215; Orexin-1) – orexin OX1 receptor antagonist
List of investigational anxiety disorder drugs
List_of_investigational_anxiety_disorder_drugs
Orexin receptor antagonist
(C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19
Fazamorexant
Chemical compound
(C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19
JNJ-10397049
Chemical compound
(C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19
Filorexant
Chemical compound
(C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19
ACT-462206
Chemical compound
(C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19
Suntinorexton
List of pharmaceutical drugs under clinical development for treatment of depression
Ropanicant (SUVN-911) – α4β2 nicotinic acetylcholine receptor antagonist Tebideutorexant (JNJ-61393215; JNJ-3215) – orexin OX1 receptor antagonist Tildacerfont
List of investigational antidepressants
List_of_investigational_antidepressants
Chemical compound
(C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19
Vornorexant
Chemical compound
(C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19
EMPA_(drug)
Chemical compound
(C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19
SB-408124
Protein-coding gene in the species Homo sapiens
(C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19
Orexin_receptor_type_2
Orexin antagonist
(C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19
TCS-OX2-29
Protein found in humans
(C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19
Hypocretin (orexin) receptor 1
Hypocretin_(orexin)_receptor_1
Chemical compound
(C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19
SB-334867
Orexin antagonist
(C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19
RTIOX-276
Chemical compound
(C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19
ACT-335827
travel, tourism, insurance
TEBIDEUTOREXANT
TEBIDEUTOREXANT
TEBIDEUTOREXANT
TEBIDEUTOREXANT
TEBIDEUTOREXANT
TEBIDEUTOREXANT
TEBIDEUTOREXANT
TEBIDEUTOREXANT
TEBIDEUTOREXANT
travel, tourism, insurance